Repair and inflammation-resolution pathways
The blend's components span four preclinical literatures: cytoprotection (BPC-157), cell migration and angiogenesis (thymosin beta-4), matrix remodeling (GHK-Cu) and anti-inflammatory signalling via melanocortin fragments (KPV). Combined formats exist for protocol convenience in multi-pathway study designs.
In plain English
KLOW is GLOW plus KPV, adding an anti-inflammatory research angle. As with all blends, the combination itself is untested in published trials.